Search for: "FTC v. Abbott Laboratories"
Results 1 - 20
of 23
Sorted by Relevance
|
Sort by Date
26 Jan 2011, 9:52 am
Lacey, Division Counsel, Abbott Laboratories I came in near the end, but Lacey emphasized that a marketer needs to know the difference between labeling (FDA authority) and other material (FTC)—if you detail to pediatricians about foods with nutritional benefits, for example, FDA largely prohibits nutrient claims for kids under 2. [read post]
30 Nov 2017, 5:47 pm
"from FTC v. [read post]
1 Oct 2010, 5:25 am
Abbott Laboratories forecast NeoProfen could be sold for $450-500 per treatment course. [read post]
22 Nov 2023, 6:44 am
(I’m here; my Manne is here, and here with Lazar Radic; former FTC General Counsel Alden Abbott says that the FTC’s complaint is “Perhaps the Greatest Affront to Consumer and Producer Welfare in Antitrust History” here). [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) … [read post]
20 May 2009, 5:18 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) Omnicef (Cefdinir) - US: CAFC rules… [read post]
19 May 2010, 6:15 am
(Patent Docs) US: CAFC affirms claim construction and corresponding summary judgment of non-infringement: Scantibodies Laboratory, Inc. v. [read post]
12 Mar 2023, 9:05 pm
They are particularly mystified by the FTC’s actions. [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al… [read post]
14 Jun 2007, 6:55 am
Abbott Laboratories, 745 A.2d 1174 (N.J. 2000). [read post]
31 May 2019, 9:47 am
Long post, lots of stuff to cover in this opinion.MillerCoors, LLC v. [read post]
31 Dec 2015, 5:12 am
Yates v. [read post]
4 Jun 2018, 3:04 pm
" Flynt v. [read post]
6 Feb 2009, 7:00 am
- Amsterdam Court of Appeal rules in favour of Hachette Filipacchi Press, publisher of Elle magazine, in trade name/trade mark infringement litigation brought by clothing company WE Netherlands (Class 46) Poland District Administrative Court in Warsaw: ALDO S and ALDI not similar (Class 46) South Africa More on the Springbok emblem (Afro-IP) Sweden Appeal Court rules on reproduction of album cover artwork in case against Åhléns (International… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
18 Apr 2008, 2:00 am
Protecting computer programs under the Copyright Act: Dais Studios v Bullet Creative: (IP Down Under), Assessing copyright risk in new classroom technologies: (IP Down Under), Cadbury loses battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks Law Blog), (IP Down Under), (IPKat), (IPwar’s), Employee or independent contractor? [read post]
28 Mar 2022, 12:50 am
FTC + State AGs Looking to Make Money? [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
